Brief: GRI Bio May Offer Up To $250 Million In Securities - SEC Filing
30/01/2026 11:09
Jan 30 (Reuters) - GRI Bio Inc GRI.O: GRI BIO INC - MAY OFFER UP TO $250 MILLION IN SECURITIES - SEC FILING Source text: [ID:n0001824293-26-000028] Further company coverage: GRI.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on GRI Bio
See all newsGRI Bio Inc reports results for the quarter ended June 30 - Earnings Summary
GRI Bio Inc expected to post a loss of $1.19 a share - Earnings Preview
Brief: Gri Bio Secures FDA Orphan Drug Designation For Gri-0621 (Tazarotene) In Idiopathic Pulmonary Fibrosis
GRI Bio Q1 net loss narrows on lower R&D expenses
GRI Bio raises $14.5 mln to fund operations into Q1 2027